Everolimus-eluting stent implantation versus repeat paclitaxel-coated balloon angioplasty for recurrent in-stent restenosis lesion caused by paclitaxel-coated balloon failure

摘要: AIMS Although paclitaxel-coated balloon (PCB) angioplasty has been reported to be effective for in-stent restenosis (ISR) lesions, the optimal treatment recurrent ISR lesions caused by PCB failure remains unclear. This study compared clinical and angiographic outcomes after everolimus-eluting stent (EES) implantation repeat failure. METHODS AND RESULTS From November 2008 October 2011, we performed 599 of which 93 underwent EES (53 52 patients) or (40 37 patients). The choice strategy was decided at operatorOs discretion. Angiographic were evaluated follow-up angiography six eight months procedure. baseline characteristics similar between two groups. At (93.5% all lesions), minimum lumen diameter significantly larger binary rate lower than (2.08±0.79 mm vs. 1.45±0.68 mm, p<0.001; 20.0% 54.1%, p=0.001; respectively), whereas late loss not different groups (0.49±0.62 0.59±0.74 p=0.47). years, incidences both target lesion revascularisation (TLR) clinically driven TLR (17.9% 57.5%, 5.9% 18.1%, p=0.01; respectively). CONCLUSIONS more in preventing subsequent because better results.